These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7902696)
1. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs. Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696 [TBL] [Abstract][Full Text] [Related]
2. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol. Ishibashi T; Mitomi A; Tatebe S; Imai S Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836 [TBL] [Abstract][Full Text] [Related]
3. Bopindolol and its metabolite 18-502 attenuate regional myocardial acidosis during partial occlusion of the coronary artery in dogs. Abiko Y; Gotoh H; Yokoyama T; Abiko T; Hashizume H; Akiyama K Arch Int Pharmacodyn Ther; 1994; 327(1):40-55. PubMed ID: 7944827 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol. Grevel J J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812 [TBL] [Abstract][Full Text] [Related]
5. [Beta-blocking actions and the partial agonist activity of bopindolol, a new beta-adrenoceptor antagonist, and its two metabolites]. Chin WP; Sun HT; Kawada T; Imai S Nihon Yakurigaku Zasshi; 1989 Jul; 94(1):27-33. PubMed ID: 2571551 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs. Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012 [TBL] [Abstract][Full Text] [Related]
7. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats. Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891 [TBL] [Abstract][Full Text] [Related]
8. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria. Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775 [TBL] [Abstract][Full Text] [Related]
9. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria. Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078 [TBL] [Abstract][Full Text] [Related]
10. Effect of beta-adrenoceptor stimulation or blockade on regional myocardial function and regional O2 consumption during myocardial ischemia. Grover GJ; Kostis JB; Weiss HR; Li JK; Kovacs T; Kedem J Arch Int Pharmacodyn Ther; 1988; 291():68-87. PubMed ID: 2896490 [TBL] [Abstract][Full Text] [Related]
11. [The effect of atenolol on the cardiovascular system (author's transl)]. Izumi T; Nishimura T; Sakai K; Abiko Y; Hattori Y; Nakaya H; Kanno M Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):505-13. PubMed ID: 6110622 [TBL] [Abstract][Full Text] [Related]
12. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity. Beaulieu G; Grimes D; Muirhead C; Oshiro G Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394 [TBL] [Abstract][Full Text] [Related]
13. The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline. Doggrell SA; Henderson CJ J Auton Pharmacol; 1998 Oct; 18(5):263-9. PubMed ID: 9831226 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869 [TBL] [Abstract][Full Text] [Related]
15. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs. Bowden CR; Marchione CS J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694 [TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor blocking effects of two bopindolol metabolites in isolated guinea-pig atria. Brasch H; Dominiak P Arzneimittelforschung; 1992 Feb; 42(2):97-100. PubMed ID: 1351728 [TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers. Nieminen MS; Rapola J; Pellinen TJ; Toivonen L Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent. Uchida W; Shibasaki K; Asano M; Takenaka T Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity. Aellig WH Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration. Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]